Statistics for Capricor Therapeutics (id:5615 CAPR)
Valuation metrics
Market cap
860.29M
Enterprise value
847.83M
Trailing P/E (ttm)
-22.43
Forward P/E
-23.36
PEG ratio
-23.36
Price/Sales (ttm)
37.04
Price/Book (mrq)
26.06
Enterprise Value/Revenue
33.67
Enterprise Value/EBITDA
-34.28
Overview
Shares outstanding
45.47M
Float
25.70M
Shares short
5.28M
% Held by insiders
0.17%
% Held by institutions
0.18%
Average volume (10 days)
1.11M
Average volume (90 days)
Price summary
52-Week low
2.90
52-Week high
23.40
52-Week change
83.89%
Beta
4.02
50-Day moving average
15.78
200-Day moving average
7.73
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
June 05th, 2019
Ex-dividend date
Last split factor
2:1
Last split date
June 05th, 2019
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
-146.86%
Operating margin
-575.24%
Operational effectiveness
Return on assets
-37.95%
Return on equity
-98.61%
Income statement
Revenue (ttm)
0.73
Revenue per share (ttm)
0.73
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-34,769,880.00
Net income to common (ttm)
-34,112,672.00
Diluted EPS (ttm)
-1.02
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
0.00
Total cash per share (mrq)
0.90
Total debt (mrq)
1.65M
Total Debt/Equity (mrq)
15.97
Current ratio (mrq)
419.15%
Book value per share (mrq)
0.73
Cash flow
Cash flow statement
-25,526,702.00
Levered free cash flow (LFCF)
-22,287,542.00